JCO Precision Oncology

Published by: American Society of Clinical Oncology  

People

  1. Drilon
    Drilon
  2. Arcila
    Arcila
  3. Ladanyi
    Ladanyi
  4. Rudin
    Rudin
  5. Kris
    Kris
  6. Offin
    Offin
  7. Chang
    Chang
  8. Rekhtman
    Rekhtman
  9. Riely
    Riely
  10. Schram
    Schram

Groups

  1. Department of Medicine (24)
  2. Solid Tumor Oncology Division (24)
  3. Thoracic Oncology (24)
  4. Department of Pathology and Laboratory Medicine (14)
  5. Weinberg Fellows (13)
  6. GSK Faculty (11)
  7. Radiology, Department of (11)
  8. Human Oncology and Pathogenesis Program (9)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (8)
  10. Graduate Medical Education (8)
Search Within
  1. "Alexander Drilon"
Formats
  1. Journal Article (23)
  2. Correspondence (1)
Groups
  1. Department of Medicine (24)
  2. Solid Tumor Oncology Division (24)
  3. Thoracic Oncology (24)
  4. Department of Pathology and Laboratory Medicine (14)
  5. Weinberg Fellows (13)
  6. GSK Faculty (11)

More Groups

People
  1. Alexander Drilon (24)
  2. Maria Arcila (7)
  3. Charles Rudin (6)
  4. Marc Ladanyi (6)
  5. David Hyman (5)
  6. Mark Kris (5)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (4)
  5. 2021 (1)
  6. 2020 (3)

More Years

Publishers
  1. American Society of Clinical Oncology (24)

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Larotrectinib compared with real-world non-tropomyosin receptor kinase inhibitor therapies in patients with tropomyosin receptor kinase fusion cancer
    Journal Article

    Brose, M. S.; Westphalen, C. B.; Pan, X.; Bernard-Gauthier, V.; Kurtinecz, M.; Guo, H.; Aris, V.; Brett, N. R.; Majdi, A.; Subbiah, V.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Early circulating tumor DNA shedding kinetics for prediction of platinum sensitivity in patients with small cell lung cancer
    Journal Article

    Murciano-Goroff, Y. R.; Hui, A. B. Y.; Araujo Filho, J. A.; Hamilton, E. G.; Chabon, J. J.; Moding, E. J.; Bonilla, R. F.; Lebow, E. S.; Gomez, D.; Rimner, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Serial cell-free DNA sequencing in ROS1 fusion-positive lung cancers during treatment with entrectinib
    Journal Article

    Choudhury, N. J.; Woo, H. J.; Chen, M.; Shah, R.; Donoghue, M.; Berger, M.; Drilon, A.
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Important considerations for real-world analysis of neurotrophic tyrosine receptor kinase fusion cancer and tropomyosin receptor kinase inhibitors
    Correspondence

    Brose, M. S.; Hong, D. S.; Drilon, A.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Amplification of wild-type RET represents a novel molecular subtype of several cancer types with clinical response to selpercatinib
    Journal Article

    Gandhi, M. M.; Ricciuti, B.; Harada, G.; Repetto, M.; Gildenberg, M. S.; Singh, A.; Li, Y. Y.; Gagné, A.; Wang, X.; Aizer, A.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Response to repotrectinib after development of NTRK resistance mutations on first- and second-generation TRK inhibitors
    Journal Article

    Chen, M. F.; Yang, S. R.; Shia, J.; Girshman, J.; Punn, S.; Wilhelm, C.; Kris, M. G.; Cocco, E.; Drilon, A.; Raj, N.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Selpercatinib-induced hypothyroidism through off-target inhibition of type 2 iodothyronine deiodinase
    Journal Article

    Boucai, L.; Salas-Lucia, F.; Krishnamoorthy, G. P.; Sherman, E.; Rudin, C. M.; Drilon, A.; Bianco, A. C.; Fagin, J. A.
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Journal Article

    Hubbeling, H.; Choudhury, N.; Flynn, J.; Zhang, Z. G.; Falcon, C.; Rusch, V. W.; Park, B. J.; Ziv, E.; Shaverdian, N.; Gelblum, D. Y.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • ALK inhibitors in patients with ALK fusion-positive GI cancers: An international data set and a molecular case series
    Journal Article

    Ambrosini, M.; Del Re, M.; Manca, P.; Hendifar, A.; Drilon, A.; Harada, G.; Ree, A. H.; Klempner, S.; Maelandsmo, G. M.; Flatmark, K.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase fusion-positive lung cancers
    Journal Article

    Drilon, A.; Tan, D. S. W.; Lassen, U. N.; Leyvraz, S.; Liu, Y.; Patel, J. D.; Rosen, L.; Solomon, B.; Norenberg, R.; Dima, L.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save

    • JCO Precision Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 Unknown
    Jco Precision Oncology Lippincott Williams & Wilkins
    Jco Precision Oncology American Society of Clinical Oncology
    Jco Precision Oncology American Society of Clinical Oncology
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    Unknown (24734284) 24734284 American Society of Clinical Oncology